Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS15AP39 is a processed pseudogene related to the ribosomal protein S15a gene in humans[2][3]. It is one of many ribosomal protein pseudogenes resulting from retrotransposition events[3]. Pseudogenes typically lack protein-coding function due to disabling mutations or truncations and do not produce functional protein products. Although some pseudogenes can influence gene regulation or serve as noncoding RNA elements, there is no evidence in current scientific literature or genomics databases that RPS15AP39 has a defined biological function or disease association. It is not considered a therapeutic target, receptor, enzyme, transporter, or biomarker[2][3][4]. If a functional role for ribosomal protein S15a is required, refer instead to RPS15A, which is a genuine ribosomal protein component of the 40S ribosomal subunit[1].\n\n**Key points:**\n- RPS15AP39 is a pseudogene, not a receptor, enzyme, transporter, or therapeutic target[2][3].\n- There is nothing to suggest clinical, therapeutic, or biomarker relevance for RPS15AP39[2][3][4].\n- The entry appears to be incorrect for any context requiring a genuine molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 39 (RPS15AP39).